Loading...
NPI 1275686123 · Indianapolis, IN · Methadone Clinic
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Indianapolis Treatment Center, LLC is a methadone clinic provider located in Indianapolis, Indiana. This profile covers 3 Medicare and 16 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Indianapolis Treatment Center, LLC |
| Address | 2626 E 46th Street |
| City | Indianapolis |
| State | IN |
| ZIP | 46205 |
| Taxonomy | Methadone Clinic |
| NPI Enumerated | January 22, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $41.4M |
| Medicare | $386.2K |
The provider is functionally an opioid treatment program focused on medication‑assisted treatment: its billing is dominated by methadone administration and MAT bundle codes such as H0020 and G2067, which correspond to methadone dispensing/administration and weekly MAT bundles that include counseling, therapy, and toxicology testing. The presence of G2074, G2078, and G2076 in the top Medicaid codes further indicates on‑site dispensing, take‑home supplies, intake/care‑planning, and bundled counseling services as routine parts of its care model.
Medicaid overwhelmingly drives this provider’s scale: total Medicaid revenue is $41.4M compared with total Medicare revenue of $386.2K, so the business is effectively Medicaid‑centric in scale and operational focus. This payer mix implies that state Medicaid program policy and reimbursement levels are primary determinants of the provider’s volume and financial performance.
Revenue concentration is very high in both programs: the precomputed top 3 Medicare codes account for 100.0% of Medicare revenue, and the top 3 Medicaid codes account for 97.5% of Medicaid revenue. That concentration indicates most of the economic activity is centered on a small set of OTP‑specific services rather than a broad mix of outpatient medical care.
Competitive standing in Medicaid is dominant for core methadone services: H0020 (1.6M claims, $25.6M revenue) ranks #1 of 28 in‑state and is labeled "notably above typical state volume for this code," and G2067 (75.7K claims, $13.6M revenue) also ranks #1 of 24 in‑state with the same "notably above typical state volume" designation. These rankings and labels identify the provider as a major statewide provider of both methadone dosing and the weekly MAT bundle.
By contrast, the provider’s Medicare activity is small in absolute dollar terms ($386.2K) but concentrated: G2067 accounts for $376.8K (97.5% of Medicare revenue) and ranks #111 of 830 nationally (87th percentile). The dataset characterizes that Medicare G2067 volume as "typical, unremarkable," so while the code captures almost all Medicare dollars for this NPI, the provider is not positioned as an unusually large national Medicare player for MAT under Medicare.
The provider also bills meaningful ancillary behavioral‑health services under Medicaid: 90792 (8.1K claims, $660.2K revenue) accounts for 1.6% of Medicaid revenue and ranks #7 of 218 in‑state (97th percentile), which the data labels "notably above typical state volume for this code." This suggests an integrated model that combines medication dispensing with psychiatric evaluation and additional clinical services.
The NPI tenure indicates established operations: the provider was enumerated on 2007-01-22 (~19 years ago), consistent with the large lifetime Medicaid volumes (e.g., 1.6M H0020 claims) and repeated high‑volume state rankings. Long tenure plus dominant in‑state rankings for core OTP codes supports the conclusion that this is an entrenched methadone clinic in the Indiana market.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 1,660 | $230 | $376.8K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 130 | $40 | $5.2K |
| G2076 | Intake activities, including initial medical examination that is conducted by an appropriately licensed practitioner and preparation of a care plan, which may be informed by administration of a… | 30 | $150 | $4.6K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 3 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
16 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 1,597,870 | $20 | $25.6M |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 75,740 | $180 | $13.6M |
| 90792 | In this procedure, the provider performs a psychiatric evaluation of the patient with the aim of making a diagnosis. In addition to the diagnostic evaluation, he also renders some additional medical… | 8,050 | $80 | $660.2K |
| G2074 | Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services… | 3,400 | $160 | $556.8K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 5,420 | $30 | $179K |
| G2076 | Intake activities, including initial medical examination that is conducted by an appropriately licensed practitioner and preparation of a care plan, which may be informed by administration of a… | 1,550 | $90 | $136.2K |
| G2068 | Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if… | 360 | $270 | $96.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 660 | $40 | $24.5K |
| G2080 | Each additional 30 minutes of counseling in a week of medication assisted treatment, (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code… | 530 | $30 | $14.9K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 550 | $20 | $12K |
Showing 1–10 of 16
How this provider's Medicaid billing volume and revenue compare to other Indiana providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Indiana median
16 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 1 | 30 | 240,980 | $20 | $6.4M |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 1 | 20 | 24,350 | $170 | $4.1M |
| T1016 | Case management, each 15 minutes | 48 | 50 | 8,980 | $30 | $3.8M |
| 90837 | In this service, the provider performs psychotherapy, a series of technique for treating the psychiatric disorders of the patient. The treatment session typically lasts for a minimum of 53 minutes or… | 683 | 690 | 1,070 | $80 | $422.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,302 | 2,380 | 920 | $50 | $376.8K |
| 90853 | Group psychotherapy is provided to a group of people who are normally not acquainted with each other but might be sharing similar kinds of psychological issues. The psychotherapist selects a group of… | 162 | 220 | 1,380 | $20 | $360.2K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 125 | 190 | 800 | $40 | $344.7K |
| G2074 | Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services… | 1 | 10 | 1,160 | $160 | $234.4K |
| H0038 | Self‑help/peer services, per 15 minutes | 78 | 80 | 1,080 | $60 | $219.4K |
| 90792 | In this procedure, the provider performs a psychiatric evaluation of the patient with the aim of making a diagnosis. In addition to the diagnostic evaluation, he also renders some additional medical… | 7 | 220 | 190 | $90 | $112.1K |
Showing 1–10 of 16
Other providers in the same ZIP code as Indianapolis Treatment Center, LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.